MedPath

University of Cagliari

University of Cagliari logo
🇮🇹Italy
Ownership
Private
Established
1606-01-01
Employees
1K
Market Cap
-
Website
http://www.unica.it

Clinical Trials

82

Active:2
Completed:38

Trial Phases

2 Phases

Phase 4:3
Not Applicable:42

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (45 trials with phase data)• Click on a phase to view related trials

Not Applicable
42 (93.3%)
Phase 4
3 (6.7%)

Ten Year Follow up of Convergent Profile Implants

Completed
Conditions
Peri-implant Bone Loss
Peri-Implant Tissues
First Posted Date
2025-07-28
Last Posted Date
2025-07-28
Lead Sponsor
University of Cagliari
Target Recruit Count
97
Registration Number
NCT07089407
Locations
🇮🇹

Cagliari University Hospital, Cagliari, Italy

Palatal Shield Technique for Graft Donor Site Healing

Not Applicable
Completed
Conditions
Palatal Wound
First Posted Date
2025-07-28
Last Posted Date
2025-07-28
Lead Sponsor
University of Cagliari
Target Recruit Count
20
Registration Number
NCT07089433
Locations
🇮🇹

Cagliari University Hospital, Cagliari, Italy

AI-Based Radiographic Detection of Periodontal Defects

Completed
Conditions
Periodontitis
First Posted Date
2025-07-25
Last Posted Date
2025-07-25
Lead Sponsor
University of Cagliari
Target Recruit Count
500
Registration Number
NCT07086625
Locations
🇮🇹

Università degli Studi di Cagliari, Cagliari, California, Italy

Prospective Multiethnic Validation of the Behçet's Syndrome Overall Damage Index (BODI)

Active, not recruiting
Conditions
Behçet's Syndrome (BS)
First Posted Date
2025-07-18
Last Posted Date
2025-07-18
Lead Sponsor
University of Cagliari
Target Recruit Count
970
Registration Number
NCT07073261
Locations
🇮🇹

Rheumatology Unit, University and AOU of Cagliari, Monserrato, Cagliari, Italy

Evaluation of the Effectiveness of a Topical Medical Device in Wound Healing and Symptom Relief in the Postoperative Period of Open Excisional Hemorrhoidectomy (The Emor Study)

Phase 4
Completed
Conditions
Anus Diseases
Gastrointestinal Diseases
Intestinal Diseases
Cicatrization
Hemorrhoids
Hemorrhoids Third Degree
Interventions
Device: Gel containing a Propionibacterium extract
Drug: Hyaluronic acid and silver sulfadiazine
First Posted Date
2025-03-12
Last Posted Date
2025-07-02
Lead Sponsor
University of Cagliari
Target Recruit Count
114
Registration Number
NCT06872151
Locations
🇮🇹

Policlinico Universitario Monserrato "Duilio Casula" - AOU Cagliari, Monserrato, Cagliari, Italy

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 17
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.